Search
Showing 289 - 300 of 302
-
Reports & Publications
Urological Cancers in Ireland 1994–2023
Three decades of National Cancer Ireland Data paint a positive picture of substantial progress on urological cancers …Publication date -
News
NCRI to Share Best Practice at Great Place to Work® Employee Wellbeing Webinar
NCRI will participate in an upcoming GPTW webinar exploring how organisations can meaningfully support employee wellbeing. … -
-
News
NCRI Website Shortlisted for a Spider Award!
The new NCRI website has been shortlisted for the “Best in Universal Design” category at the upcoming Spider Awards. … -
Reports & Publications
Fast Facts: Prostate Cancer
Fact Facts: Prostate Cancer Prostate Cancer is the most commonly diagnosed urological cancer It is the most common cancer in men in Ireland excl. NMSC 94% of patients are alive five years after a prostate cancer diagnosis Prostate cancer survival is among … -
Reports & Publications
Fast Facts: Urological Cancers
Fact Facts: Urological Cancers There are 5 types of Urological cancers: prostate, testis, penis, kidney, bladder Survival has improved or remained stable across all urological cancers Case numbers have risen over time, driven by Ireland’s ageing … -
About us
NCRI is the State Agency responsible for collecting and analysing cancer data, to inform policy, patient care and planning for services in … -
News
NCRI Recruitment Campaign: Electronic Cancer Data Registrar
The National Cancer Registry Ireland (NCRI) is pleased to announce a new recruitment campaign for an Electronic Cancer Data Registrar. … -
About NCRI
Corporate services
Corporate services at NCRI supports operational efficiency by managing human resources, finance, communication, and administration functions essential for the organisation's … -
-
News
Best Workplaces™ for Health & Wellbeing 2026
NCRI recognised as one of Ireland’s Best Workplaces for Health & Wellbeing 2026 … -
Contact us
This page contains all the information you need to contact NCRI. To contact our various teams or to send us an enquiry, please see the options …